Dr. Bollinger is a clinician-scientist who joined GHSU in 2009. She holds a Ph.D. degree from the Medical College of Wisconsin (MCW) in the area of photopigment genes and defective color vision. Her work was conducted with Dr. Maureen Neitz. Dr. Bollinger earned her MD degree from MCW and completed her ophthalmology residency at the Cole Eye Institute, Cleveland Clinic during which time she worked with Dr. Stephanie Hagstrom elucidating the functions of TULP1 gene expression and intracellular protein sorting. In 2007, Dr. Bollinger was awarded a Glaucoma Fellowship at the Cole Eye Institute, which she completed in 2008. During that fellowship, Dr. Bollinger was involved in a biomarker discovery study related to primary open angle glaucoma (POAG). She has a keen interest in identifying biomarkers for POAG and is now working with VDI colleague Dr. Lane Ulrich to establish an aqueous humor repository that can be useful for this project. Dr. Bollinger was recently awarded a Mentored Clinical Scientist Development award (K08) from the NEI. She is working with Dr. Sylvia Smith investigating molecular mechanisms underlying sigma 1 mediated retinal ganglion cell protection. Her laboratory has optimized isolation of optic nerve astrocytes from sigma 1 KO mice. Several VDI faculty members are serving on Dr. Bollinger’s advisory committee including Drs. Atherton, Ganapathy and Caldwell as well as Vanderbilt vision researcher Dr. David Calkins.